(Q82744393)

English

Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype

scientific article published on 01 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

neoplastic stem cells

1 reference

based on heuristic

inferred from title

systemic therapy

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kenneth S Koeneman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

119-121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

CD133, a novel marker for human prostatic epithelial stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Telomerase as a new target for the treatment of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Recent advances in telomere biology: implications for human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The signals and pathways activating cellular senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The development of differentiation agents for the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Identifiers

10.1016/J.UROLONC.2005.11.031

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82744393&oldid=1710338775"